Page 155 - CW E-Magazine (1-10-2024)

News from Abroad

The company currently operates profitable as a company in advance of The site is strategically located to
one of the largest dairy-based renew- our Net-Zero 1 project’s (SAF project serve both the US and Canadian mar-
able natural gas (RNG) facilities in in Lake Preston, South Dakota) com- kets. It provides Gevo with a wholly-
the US and owns the world’s first mercial operation. Not only are we owned CCS asset and additional supply
alcohol-to-jet (ATJ) fuels and chemicals securing an excellent site for additional of low-carbon intensity ethanol.
production facility. Through its Verity SAF asset deployment, but we also miti-
subsidiary, Gevo tracks and verifies gate risk around carbon sequestration “The acquisition includes existing
the carbon footprint of its operations to regarding our Net-Zero 1 plant site in CCS assets with total sequestration
ensure sustainability. South Dakota. This acquisition gives capacity of 1-mtpa, of which 160,000-tpa
us the opportunity to build capability are currently being utilised. This site
The acquired assets in North Dakota, as a company and is a terrific training could accommodate many future net-
when combined with Gevo’s RNG ground for our Net-Zero 1 project, as zero-type and related projects. The
business and other ventures like Verity, we inherit a trained cadre of employees acquisition accelerates Gevo’s fun-
are projected to turn Gevo’s earnings who understand plant operations.” damental capabilities related to feed-
positive in 2025. stock procurement, plant operations,
The Red Trail Energy facility offers and the business of carbon abatement,
Gevo’s CEO, Dr. Patrick Gruber, a “net-zero” site that will facilitate which are expected to benefit Net-
said, “This immediately puts us on a future production of SAF with a low- Zero 1 and other future SAF projects,
path to becoming self-sustaining and carbon footprint, Gevo said. ” Gevo said.

EXPANDING FOOTPRINT
Thermo Fisher Scientific setting up new bioanalytical

laboratory in Sweden

The PPD clinical research business Health Innovation City –
of US-based analytical technologies as we deploy the most
firm, Thermo Fisher Scientific, has technologically ad-
announced plans to set up a new bio- vanced systems to
analytical lab in GoCo Health Innova- develop assays sup-
tion City in Gothenburg, Sweden, that porting early disco-
will serve pharmaceutical and biotech very and subsequently
customers with advanced laboratory apply them for testing
services and instrumentation across all of clinical trial sam-
phases of pharmaceutical development. ples across every stage
cell-based assays, chromatography, flow of drug development for our custo-
The new 29,000-sq.ft. lab` will be cytometry, immunochemistry and mole- mers,” said Mr. Leon Wyszkowski,
adjacent to the Gothenburg strategic R&D cular genomics. The new lab, which is ex- President, analytical services, clinical
site of AstraZeneca, which has been pected to be completed in the fourth quar- research, Thermo Fisher Scientific.
instrumental in the development of GoCo ter of 2025, will be equipped with state-of-
Health Innovation City – a planned re- the-art instrumentation, enabling a wide In addition to the new lab in Sweden,
search cluster to accelerate health inno- range of GLP-compliant bioanalytical the PPD clinical research business
vation. The PPD clinical research business capabilities. This advanced technology operates a global network of GMP
will expand its bioanalytical capabilities will facilitate the delivery of rapid and reli- (good manufacturing practices), central,
to include comprehensive and full-ser- able bioanalytical assay services across all bioanalytical and vaccine science
vice solutions, encompassing both small stages of drug development, from pre- laboratories with operations based
and large molecules, biomarkers and clinical studies to post-approval studies. in Middleton, Wisconsin, Highland
novel modalities. Service offerings will “We are thrilled to expand our bioanalytical Heights, Kentucky, Richmond, Virginia,
include a wide range of advanced tech- footprint in Europe – in the collabora- Athlone, Ireland, Brussels, Belgium,
nologies and methodologies, such as tive and innovative environment of GoCo Singapore and Suzhou, China.

Chemical Weekly October 1, 2024 155

Contents Index to Advertisers Index to Products Advertised